Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples